No insider purchase over the last 90 days. The latest was filed 10 Jul 2026.
GRANGEX AB (publ) is a Chemicals company. Its directors and officers file their transactions with Finansinspektionen. In the past year (18 October 2025 to 18 October 2026), 2 filings came from 2 insiders.
The record shows 1 purchase on the open market worth €417k, made by 1 insider, against 1 sale worth €417k by 1 insider. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 1 chief executive among the declarants. One trade stands out by size: a sale of €417k from Christer Lindqvist, disclosed on 10 July 2026, or 1.1% of market capitalisation.
Compared with its exchange (890 companies, median 7 filings), a count of 2 filings is below the norm. Looking back to 2025, when coverage begins, insiders filed 1 purchase and 3 sales.
The last purchase on record was published on 10 July 2026, which is 99 days ago.
Elsewhere in the same sector, our signals recently picked up insider purchases at Culp Inc and Gold.com, Inc. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
FY ended December 2025 · cache
6 of 6 declarations
GRANGEX AB (Publ) is a publicly traded company on the XSTO exchange, specializing in the chemistry and materials sector. It focuses on the development and production of innovative solutions in this field.
Purchases our model currently ranks for the recommendations list.
All recommendations